Melanoma is the cancer with the highest increase in incidence, and transformation of radial growth to vertical growth (i.e., noninvasive to invasive) melanoma is required for invasive disease and metastasis. We have previously shown that p42/p44 MAP kinase is activated in radial growth melanoma, suggesting that further signaling events are required for vertical growth melanoma. The molecular events that accompany this transformation are not well understood. Akt, a signaling molecule downstream of PI3K, was introduced into the radial growth WM35 melanoma in order to test whether Akt overexpression is sufficient to accomplish this transformation. Overexpression of Akt led to upregulation of VEGF, increased production of superoxide ROS, and the switch to a more pronounced glycolytic metabolism. Subcutaneous implantation of WM35 cells overexpressing Akt led to rapidly growing tumors in vivo, while vector control cells did not form tumors. We demonstrated that Akt was associated with malignant transformation of melanoma through at least 2 mechanisms. First, Akt may stabilize cells with extensive mitochondrial DNA mutation, which can generate ROS. Second, Akt can induce expression of the ROS-generating enzyme NOX4. Akt thus serves as a molecular switch that increases angiogenesis and the generation of superoxide, fostering more aggressive tumor behavior. Targeting Akt and ROS may be of therapeutic importance in treatment of advanced melanoma.
Baskaran Govindarajan, James E. Sligh, Bethaney J. Vincent, Meiling Li, Jeffrey A. Canter, Brian J. Nickoloff, Richard J. Rodenburg, Jan A. Smeitink, Larry Oberley, Yuping Zhang, Joyce Slingerland, Rebecca S. Arnold, J. David Lambeth, Cynthia Cohen, Lu Hilenski, Kathy Griendling, Marta Martínez-Diez, José M. Cuezva, Jack L. Arbiser
Title and authors | Publication | Year |
---|---|---|
LPCAT1 promotes melanoma cell proliferation via Akt signaling
Wang Y, Huang Y, Wang Y, Zhang W, Wang N, Bai R, Luo R, Tuo H, Zheng Y |
Oncology reports | 2024 |
Melanoma progression and prognostic models drawn from single-cell, spatial maps of benign and malignant tumors
Love NR, Williams C, Killingbeck EE, Merleev A, Saffari Doost M, Yu L, McPherson JD, Mori H, Borowsky AD, Maverakis E, Kiuru M |
Science Advances | 2024 |
Oxidative State in Cutaneous Melanoma Progression: A Question of Balance
Benedusi M, Lee H, Lim Y, Valacchi G |
Antioxidants | 2024 |
Current Insights into the Role of UV Radiation-Induced Oxidative Stress in Melanoma Pathogenesis
Gieniusz E, Skrzydlewska E, Łuczaj W |
International Journal of Molecular Sciences | 2024 |
The role of mitochondria in the resistance of melanoma to PD-1 inhibitors.
Du F, Yang LH, Liu J, Wang J, Fan L, Duangmano S, Liu H, Liu M, Wang J, Zhong X, Zhang Z, Wang F |
Journal of Translational Medicine | 2023 |
The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches.
Emanuelli M, Sartini D, Molinelli E, Campagna R, Pozzi V, Salvolini E, Simonetti O, Campanati A, Offidani A |
2022 | |
Indolium 1 Exerts Activity against Vemurafenib-Resistant Melanoma In Vivo
Radi R, Huang C, Elsey J, Jung YH, Corces VG, Arbiser JL |
Antioxidants | 2022 |
DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype
Adriana Sanna, Bengt Phung, Shamik Mitra, Martin Lauss, Jiyeon Choi, Tongwu Zhang, Ching-Ni Jenny Njauw, Eugenia Cordero, Katja Harbst, Frida Rosengren, Rita Cabrita, Iva Johansson, Karolin Isaksson, Christian Ingvar, Ana Carneiro, Kevin Brown, Hensin Tsao, My Andersson, Kristian Pietras, Göran Jönsson |
JCI Insight | 2022 |
Cytoglobin inhibits non-thermal plasma-induced apoptosis in melanoma cells through regulation of the NRF2-mediated antioxidant response
De Backer J, Lin A, Berghe WV, Bogaerts A, Hoogewijs D |
Redox Biology | 2022 |
Role of ROS-mediated autophagy in melanoma
Zhang X, Li H, Liu C, Yuan X |
Molecular medicine reports | 2022 |
Mitochondrial Metabolism in Melanoma
C Huang, RH Radi, JL Arbiser |
Cells | 2021 |
Signal pathways of melanoma and targeted therapy
W Guo, H Wang, C Li |
Signal Transduction and Targeted Therapy | 2021 |
NADPH Oxidases (NOX): An Overview from Discovery, Molecular Mechanisms to Physiology and Pathology
A Vermot, I Petit-Härtlein, SM Smith, F Fieschi |
Antioxidants | 2021 |
Cross-Talk between Oxidative Stress and m6A RNA Methylation in Cancer
B Yang, Q Chen, X Zhan |
Oxidative Medicine & Cellular Longevity | 2021 |
Oxidative Stress in Cancer Cell Metabolism
S Arfin, NK Jha, SK Jha, KK Kesari, J Ruokolainen, S Roychoudhury, B Rathi, D Kumar |
Antioxidants | 2021 |
Genetic deletion of Nox4 enhances cancerogen-induced formation of solid tumors
V Helfinger, FF von Gall, N Henke, MM Kunze, T Schmid, F Rezende, J Heidler, I Wittig, HH Radeke, V Marschall, K Anderson, AM Shah, S Fulda, B Brüne, RP Brandes, K Schröder |
Proceedings of the National Academy of Sciences | 2021 |
ROS as Regulators of Cellular Processes in Melanoma
I Venza, M Venza, M Visalli, G Lentini, D Teti, FS d'Alcontres, J Egea |
Oxidative Medicine & Cellular Longevity | 2021 |
RGD-targeted redox responsive nano micelle: co-loading docetaxel and indocyanine green to treat the tumor
L Ren, J Nie, J Wei, Y Li, J Yin, X Yang, G Chen |
Drug Delivery | 2021 |
ROS Pleiotropy in Melanoma and Local Therapy with Physical Modalities
SK Sagwal, S Bekeschus, B Duan |
Oxidative Medicine & Cellular Longevity | 2021 |
Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted Therapies
S Pizzimenti, S Ribero, M Cucci, M Grattarola, C Monge, C Dianzani, G Barrera, G Muzio |
Antioxidants | 2021 |
NOX2-Derived Reactive Oxygen Species in Cancer
HG Wiktorin, E Aydin, K Hellstrand, A Martner, J Ghose |
Oxidative Medicine & Cellular Longevity | 2020 |
Role of Melanin Chemiexcitation in Melanoma Progression and Drug Resistance
S Premi |
Frontiers in Oncology | 2020 |
Tumor growth rate as a prognostic factor of acral melanoma in a Korean population
G Jo, SI Cho, Y Cho, J Ohn, JH Mun |
Medicine | 2020 |
Akt3 induces oxidative stress and DNA damage by activating the NADPH oxidase via phosphorylation of p47 phox
C Polytarchou, M Hatziapostolou, TO Yau, N Christodoulou, PW Hinds, F Kottakis, I Sanidas, PN Tsichlis |
Proceedings of the National Academy of Sciences | 2020 |
Highly efficient singlet oxygen generation, two-photon photodynamic therapy and melanoma ablation by rationally designed mitochondria-specific near-infrared AIEgens
Z Zheng, H Liu, S Zhai, H Zhang, G Shan, RT Kwok, C Ma, HH Sung, ID Williams, JW Lam, KS Wong, X Hu, BZ Tang |
Chemical Science | 2020 |
Uncovering the Underlying Mechanisms of Cancer Metabolism through the Landscapes and Probability Flux Quantifications
W Li, J Wang |
iScience | 2020 |
A20 promotes melanoma progression via the activation of Akt pathway
J Ma, H Wang, S Guo, X Yi, T Zhao, Y Liu, Q Shi, T Gao, C Li, W Guo |
Cell Death and Disease | 2020 |
The multifaceted role of reactive oxygen species in tumorigenesis.
Kirtonia A, Sethi G, Garg M |
Cellular and molecular life sciences : CMLS | 2020 |
AKT1 E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis
DA Kircher, KA Trombetti, MR Silvis, GL Parkman, GM Fischer, SN Angel, CM Stehn, SC Strain, AH Grossmann, KL Duffy, KM Boucher, M McMahon, MA Davies, MC Mendoza, MW VanBrocklin, SL Holmen |
Molecular cancer research : MCR | 2019 |
Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy
Chamcheu, Roy, Uddin, BM, Chamcheu, Walker, Liu, Huang |
Cells | 2019 |
Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements
V Aggarwal, H Tuli, A Varol, F Thakral, M Yerer, K Sak, M Varol, A Jain, Khan, G Sethi |
Biomolecules | 2019 |
Regulation of Tumor Progression by Programmed Necrosis
SY Lee, MK Ju, HM Jeon, EK Jeong, YJ Lee, CH Kim, HG Park, SI Han, HS Kang |
Oxidative medicine and cellular longevity | 2018 |
Oncogenic Metabolism Acts as a Prerequisite Step for Induction of Cancer Metastasis and Cancer Stem Cell Phenotype
SY Lee, MK Ju, HM Jeon, YJ Lee, CH Kim, HG Park, SI Han, HS Kang |
Oxidative medicine and cellular longevity | 2018 |
The interplay of reactive oxygen species and the epidermal growth factor receptor in tumor progression and drug resistance
MS Weng, JH Chang, WY Hung, YC Yang, MH Chien |
Journal of Experimental & Clinical Cancer Research | 2018 |
AKT1 restricts the invasive capacity of head and neck carcinoma cells harboring a constitutively active PI3 kinase activity
S Brolih, SK Parks, V Vial, J Durivault, L Mostosi, J Pouysségur, G Pagès, V Picco |
BMC Cancer | 2018 |
NOX2 inhibition reduces oxidative stress and prolongs survival in murine KRAS-induced myeloproliferative disease
E Aydin, A Hallner, HG Wiktorin, A Staffas, K Hellstrand, A Martner |
Oncogene | 2018 |
Akt‐mediated phosphorylation of MICU1 regulates mitochondrial Ca 2+ levels and tumor growth
S Marchi, M Corricelli, A Branchini, VA Vitto, S Missiroli, G Morciano, M Perrone, M Ferrarese, C Giorgi, M Pinotti, L Galluzzi, G Kroemer, P Pinton |
The EMBO Journal | 2018 |
NADPH Oxidase Deficiency: A Multisystem Approach
G Giardino, MP Cicalese, O Delmonte, M Migliavacca, B Palterer, L Loffredo, E Cirillo, V Gallo, F Violi, C Pignata |
Oxidative medicine and cellular longevity | 2017 |
Antitumor agent 25-epi Ritterostatin GN1N induces endoplasmic reticulum stress and autophagy mediated cell death in melanoma cells
KB Ahmed, AK Kanduluru, L Feng, PL Fuchs, P Huang |
International journal of oncology | 2017 |
Cooperation between p21 and Akt is required for p53-dependent cellular senescence
YY Kim, HJ Jee, JH Um, YM Kim, SS Bae, J Yun |
Aging Cell | 2017 |
Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation
SY Lee, EK Jeong, MK Ju, HM Jeon, MY Kim, CH Kim, HG Park, SI Han, HS Kang |
Molecular Cancer | 2017 |
Influence of node abundance on signaling network state and dynamics analyzed by mass cytometry
XK Lun, VR Zanotelli, JD Wade, D Schapiro, M Tognetti, N Dobberstein, B Bodenmiller |
Nature Biotechnology | 2017 |
NADPH Oxidases: Insights into Selected Functions and Mechanisms of Action in Cancer and Stem Cells
M Skonieczna, T Hejmo, A Poterala-Hejmo, A Cieslar-Pobuda, RJ Buldak |
Oxidative medicine and cellular longevity | 2017 |
Targeting the duality of cancer
JL Arbiser, MY Bonner, LC Gilbert |
npj Precision Oncology | 2017 |
Toxicity and Immunogenicity in Murine Melanoma following Exposure to Physical Plasma-Derived Oxidants
S Bekeschus, K Rödder, B Fregin, O Otto, M Lippert, KD Weltmann, K Wende, A Schmidt, RK Gandhirajan |
Oxidative medicine and cellular longevity | 2017 |
Transcriptome Analysis of Canine Cutaneous Melanoma and Melanocytoma Reveals a Modulation of Genes Regulating Extracellular Matrix Metabolism and Cell Cycle
C Brachelente, K Cappelli, S Capomaccio, I Porcellato, S Silvestri, L Bongiovanni, RD Maria, AV Supplizi, L Mechelli, M Sforna |
Scientific Reports | 2017 |
Macrophage Akt1 Kinase-Mediated Mitophagy Modulates Apoptosis Resistance and Pulmonary Fibrosis
JL Larson-Casey, JS Deshane, AJ Ryan, VJ Thannickal, AB Carter |
Immunity | 2016 |
Melanoma Brain Metastasis: Mechanisms, Models, and Medicine
D Kircher, M Silvis, J Cho, S Holmen |
International journal of molecular sciences | 2016 |
Propranolol induced G0/G1/S phase arrest and apoptosis in melanoma cells via AKT/MAPK pathway
C Zhou, X Chen, W Zeng, C Peng, G Huang, X Li, Z Ouyang, Y Luo, X Xu, B Xu, W Wang, R He, X Zhang, L Zhang, J Liu, TC Knepper, Y He, HL McLeod |
Oncotarget | 2016 |
Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo.
Bonner MY, Karlsson I, Rodolfo M, Arnold RS, Vergani E, Arbiser JL |
Oncotarget | 2016 |
Metabolic changes associated with tumor metastasis, part 2: Mitochondria, lipid and amino acid metabolism
PE Porporato, VL Payen, B Baselet, P Sonveaux |
Cellular and Molecular Life Sciences | 2015 |
Cellular Mechanisms of Oxidative Stress and Action in Melanoma
M Venza, M Visalli, C Beninati, GV de Gaetano, D Teti, I Venza |
Oxidative medicine and cellular longevity | 2015 |
NUAK2 Amplification Coupled with PTEN Deficiency Promotes Melanoma Development via CDK Activation
T Namiki, T Yaguchi, K Nakamura, JC Valencia, SG Coelho, L Yin, M Kawaguchi, WD Vieira, Y Kaneko, A Tanemura, I Katayama, H Yokozeki, Y Kawakami, VJ Hearing |
Cancer research | 2015 |
Mechanisms of Superoxide Signaling in Epigenetic Processes: Relation to Aging and Cancer
I Afanas’ev |
Aging and disease | 2015 |
NOX4-driven ROS formation mediates PTP inactivation and cell transformation in FLT3ITD-positive AML cells
AK Jayavelu, JP Müller, R Bauer, SA Böhmer, J Lässig, S Cerny-Reiterer, WR Sperr, P Valent, B Maurer, R Moriggl, K Schröder, AM Shah, M Fischer, S Scholl, J Barth, T Oellerich, T Berg, H Serve, S Frey, T Fischer, FH Heidel, FD Böhmer |
Leukemia | 2015 |
The T-box transcription factor, TBX3, is a key substrate of AKT3 in melanomagenesis.
Peres J, Mowla S, Prince S |
Oncotarget | 2015 |
NADPH Oxidases in Vascular Pathology
A Konior, A Schramm, M Czesnikiewicz-Guzik, TJ Guzik |
Antioxidants & Redox Signaling | 2014 |
Fisetin inhibits human melanoma cell growth through direct binding to p70S6K and mTOR: Findings from 3-D melanoma skin equivalents and computational modeling
DN Syed, JC Chamcheu, MI Khan, M Sechi, RK Lall, VM Adhami, H Mukhtar |
Biochemical Pharmacology | 2014 |
Melanocytes as Instigators and Victims of Oxidative Stress
L Denat, AL Kadekaro, L Marrot, SA Leachman, ZA Abdel-Malek |
Journal of Investigative Dermatology | 2014 |
PHIPing Out: A Genetic Basis for Tumor Ulceration
JL Arbiser |
Journal of Investigative Dermatology | 2014 |
Updates of reactive oxygen species in melanoma etiology and progression
F Liu-Smith, R Dellinger, FL Meyskens |
Archives of Biochemistry and Biophysics | 2014 |
Current approaches to the treatment of metastatic brain tumours
TK Owonikoko, J Arbiser, A Zelnak, HK Shu, H Shim, AM Robin, SN Kalkanis, TG Whitsett, B Salhia, NL Tran, T Ryken, MK Moore, KM Egan, JJ Olson |
Nature Reviews Clinical Oncology | 2014 |
Butein suppresses breast cancer growth by reducing a production of intracellular reactive oxygen species
SG Cho, SM Woo, SG Ko |
Journal of Experimental & Clinical Cancer Research | 2014 |
Amyloids, melanins and oxidative stress in melanomagenesis
F Liu-Smith, C Poe, PJ Farmer, FL Meyskens |
Experimental Dermatology | 2014 |
The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer
MY Bonner, JL Arbiser |
Future Medicinal Chemistry | 2014 |
In vitro evaluation of novel N-acetylalaninate prodrugs that selectively induce apoptosis in prostate cancer cells
CA McGoldrick, YL Jiang, M Brannon, K Krishnan, WL Stone |
BMC Cancer | 2014 |
A Signal Transduction Pathway from TGF-β1 to SKP2 via Akt1 and c-Myc and its Correlation with Progression in Human Melanoma
X Qu, L Shen, Y Zheng, Y Cui, Z Feng, F Liu, J Liu |
Journal of Investigative Dermatology | 2014 |
Regulation of NADPH-dependent Nitric Oxide and reactive oxygen species signalling in endothelial and melanoma cells by a photoactive NADPH analogue
Rouaud F, Romero-Perez M, Wang H, Lobysheva I, Ramassamy B, Henry E, Tauc P, Giacchero D, Boucher JL, Deprez E, Rocchi S, Slama-Schwok A |
Oncotarget | 2014 |
Effects of Iodonium-Class Flavin Dehydrogenase Inhibitors on Growth, Reactive Oxygen Production, Cell Cycle Progression, NADPH Oxidase 1 Levels, and Gene Expression in Human Colon Cancer Cells and Xenografts
JH Doroshow, S Gaur, S Markel, J Lu, J Balgooy, TW Synold, B Xi, X Wu, A Juhasz |
Free radical biology & medicine | 2013 |
Characterization of NADPH oxidase 5 expression in human tumors and tumor cell lines with a novel mouse monoclonal antibody
S Antony, Y Wu, SM Hewitt, MR Anver, D Butcher, G Jiang, JL Meitzler, H Liu, A Juhasz, J Lu, KK Roy, JH Doroshow |
Free radical biology & medicine | 2013 |
RedOx status, proteasome and APEH: insights into anticancer mechanisms of t10,c12-conjugated linoleic acid isomer on A375 melanoma cells
P Bergamo, E Cocca, R Palumbo, M Gogliettino, M Rossi, G Palmieri |
PloS one | 2013 |
Nox-derived ROS are acutely activated in pressure overload pulmonary hypertension: indications for a seminal role for mitochondrial Nox4
G Frazziano, IA Ghouleh, J Baust, S Shiva, HC Champion, PJ Pagano |
American journal of physiology. Heart and circulatory physiology | 2013 |
Pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasis
DD Semir, M Nosrati, V Bezrookove, AA Dar, S Federman, G Bienvenu, S Venna, J Rangel, J Climent, TM Tamgüney, S Thummala, S Tong, SP Leong, C Haqq, P Billings, JR 3rd, RW Sagebiel, R Debs, M Kashani-Sabet |
Proceedings of the National Academy of Sciences | 2012 |
High expression of GCLC is associated with malignant melanoma of low oxidative phenotype and predicts a better prognosis
D Mougiakakos, R Okita, T Ando, C Dürr, J Gadiot, J Ichikawa, R Zeiser, C Blank, CC Johansson, R Kiessling |
Journal of Molecular Medicine | 2012 |
Thiostrepton is an Inducer of Oxidative and Proteotoxic Stress that Impairs Viability of Human Melanoma Cells but not Primary Melanocytes
S Qiao, SD Lamore, CM Cabello, JL Lesson, JL Muñoz-Rodriguez, GT Wondrak |
Biochemical Pharmacology | 2012 |
Targeting NADPH oxidases for the treatment of cancer and inflammation
MY Bonner, JL Arbiser |
Cellular and Molecular Life Sciences | 2012 |
Role of apoptosis-inducing factor, proline dehydrogenase, and NADPH oxidase in apoptosis and oxidative stress
SK Natarajan, DF Becker |
Cell health and cytoskeleton | 2012 |
Jacaranone Induces Apoptosis in Melanoma Cells via ROS-Mediated Downregulation of Akt and p38 MAPK Activation and Displays Antitumor Activity In Vivo
MH Massaoka, AL Matsuo, CR Figueiredo, CF Farias, N Girola, DC Arruda, JA Scutti, P Romoff, OA Favero, MJ Ferreira, JH Lago, LR Travassos |
PloS one | 2012 |
Aiding and abetting roles of NOX oxidases in cellular transformation
K Block, Y Gorin |
Nature Reviews Cancer | 2012 |
A phosphatidylinositol 3-kinase-Pax3 axis regulates Brn-2 expression in melanoma
E Bonvin, P Falletta, H Shaw, V Delmas, CR Goding |
Molecular and cellular biology | 2012 |
1,3-Bis(3,5-dichlorophenyl) urea compound 'COH-SR4' inhibits proliferation and activates apoptosis in melanoma
SS Singhal, J Figarola, J Singhal, K Leake, L Nagaprashantha, C Lincoln, BG Gugiu, D Horne, R Jove, S Awasthi, S Rahbar |
Biochemical Pharmacology | 2012 |
Glutamine-fueled mitochondrial metabolism is decoupled from glycolysis in melanoma
FV Filipp, B Ratnikov, JD Ingeniis, JW Smith, AL Osterman, DA Scott |
Pigment Cell & Melanoma Research | 2012 |
Redox signaling in cardiac myocytes
CX Santos, N Anilkumar, M Zhang, AC Brewer, AM Shah |
Free radical biology & medicine | 2011 |
Therapeutic Implications of Targeting AKT Signaling in Melanoma
SV Madhunapantula, GP Robertson |
Enzyme Research | 2011 |
Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth
Q Sun, X Chen, J Ma, H Peng, F Wang, X Zha, Y Wang, Y Jing, H Yang, R Chen, L Chang, Y Zhang, J Goto, H Onda, T Chen, MR Wang, Y Lu, H You, D Kwiatkowski, H Zhang |
Proceedings of the National Academy of Sciences | 2011 |
Cytoplasmic Skp2 expression is increased in human melanoma and correlated with patient survival
G Chen, Y Cheng, Z Zhang, M Martinka, G Li |
PloS one | 2011 |
The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis
CM Cabello, SD Lamore, WB Bair, S Qiao, S Azimian, JL Lesson, GT Wondrak |
Investigational New Drugs | 2011 |
NADPH Oxidase Activation Is Required in Reactive Oxygen Species Generation and Cell Transformation Induced by Hexavalent Chromium
X Wang, YO Son, Q Chang, L Sun, JA Hitron, A Budhraja, Z Zhang, Z Ke, F Chen, J Luo, X Shi |
Toxicological Sciences | 2011 |
Effective inhibition of melanoma by BI-69A11 is mediated by dual targeting of the AKT and NF-κB pathways
Y Feng, E Barile, SK De, JL Stebbins, A Cortez, P Aza-Blanc, J Villanueva, M Heryln, S Krajewski, M Pellecchia, ZA Ronai, GG Chiang |
Pigment Cell & Melanoma Research | 2011 |
Resveratrol Modulates the Malignant Properties of Cutaneous Melanoma via Changes in the Activation and Attenuation of the Anti-apoptotic Proto-oncogenic Protein Akt/PKB
S Bhattacharya, SR Darjatmoko, AS Polans |
Melanoma Research | 2011 |
Inhibition of human melanoma cell growth by dietary flavonoid fisetin is associated with disruption of Wnt/β-catenin signaling and decreased Mitf levels
DN Syed, F Afaq, N Maddodi, JJ Johnson, S Sarfaraz, A Ahmad, V Setaluri, H Mukhtar |
Journal of Investigative Dermatology | 2011 |
An extracellular signal-regulated kinase 2 survival pathway mediates resistance of human mesothelioma cells to asbestos-induced injury
A Shukla, TF Barrett, MB MacPherson, JM Hillegass, NK Fukagawa, WA Swain, KJ O'Byrne, JR Testa, HI Pass, SP Faux, BT Mossman |
American journal of respiratory cell and molecular biology | 2011 |
Roles of AKT1 and AKT2 in non‐small cell lung cancer cell survival, growth, and migration
Lee MW, Kim DS, Lee JH, Lee BS, Lee SH, Jung HL, Sung KW, Kim HT, Yoo KH, Koo HH |
Cancer Science | 2011 |
Survivin enhances motility of melanoma cells by supporting Akt activation and α5 integrin upregulation
JA McKenzie, T Liu, AG Goodson, D Grossman |
Cancer research | 2010 |
GLO1 overexpression in human malignant melanoma
WB 3rd, CM Cabello, K Uchida, AS Bause, GT Wondrak |
Melanoma Research | 2010 |
Effects of HIF-1alpha and HIF2alpha on Growth and Metabolism of Clear-Cell Renal Cell Carcinoma 786-0 Xenografts
S Biswas, H Troy, R Leek, YL Chung, JL Li, RR Raval, H Turley, K Gatter, F Pezzella, JR Griffiths, M Stubbs, AL Harris |
Journal of Oncology | 2010 |
Inhibitory effects of Lang-du extract on the in vitro and in vivo growth of melanoma cells and its molecular mechanisms of action
L Wang, H Duan, Y Wang, K Liu, P Jiang, Z Qu, K Yagasaki, G Zhang |
Cytotechnology | 2010 |
AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1)
SS Shin, BA Wall, JS Goydos, S Chen |
Pigment Cell & Melanoma Research | 2010 |
Fyn is Induced by Ras/PI3K/Akt Signaling and is Required for Enhanced Invasion/Migration
V Yadav, MF Denning |
Molecular Carcinogenesis | 2010 |
NADPH Oxidase Activation in Pancreatic Cancer Cells Is Mediated through Akt-dependent Up-regulation of p22phox*
M Edderkaoui, C Nitsche, L Zheng, SJ Pandol, I Gukovsky, AS Gukovskaya |
The Journal of biological chemistry | 2010 |
Melanoma Chemoprevention in Skin Reconstructs and Mouse Xenografts Using Isoselenocyanate-4
N Nguyen, A Sharma, N Nguyen, AK Sharma, D Desai, SJ Huh, S Amin, C Meyers, GP Robertson |
Cancer prevention research (Philadelphia, Pa.) | 2010 |
Metastasis in an Orthotopic Murine Model of Melanoma is Independent of RAS/RAF Mutation
GI Rozenberg, KB Monahan, C Torrice, JE Bear, NE Sharpless |
Melanoma Research | 2010 |
Reactive oxygen species in cancer
GY Liou, P Storz |
Free Radical Research | 2010 |
Vertical Targeting of the Phosphatidylinositol-3 Kinase Pathway as a Strategy for Treating Melanoma
SA Aziz, LB Jilaveanu, C Zito, RL Camp, DL Rimm, P Conrad, HM Kluger |
Clinical cancer research | 2010 |
Akt3-Mediated Resistance to Apoptosis in B-RAF–Targeted Melanoma Cells
Y Shao, AE Aplin |
Cancer research | 2010 |
Requirement of NADPH oxidase 4 (Nox4) for hemangioma growth in vivo, and discovery of fulvenes as small molecular NADPH oxidase inhibitors
Sulochana S. Bhandarkar, Marisa Jaconi, Benjamin Lefkove, Levi Fried, Baskaran Govindarajan, Betsy N. Perry, Allie Sohn, Michael Stouffs, Ulla Knaus, George Yancopoulos, Hellmut Augustin, Jack Arbiser |
Journal of Clinical Investigation | 2009 |
Functional RET G691S polymorphism in cutaneous malignant melanoma
N Narita, A Tanemura, R Murali, RA Scolyer, S Huang, T Arigami, S Yanagita, KK Chong, JF Thompson, DL Morton, DS Hoon |
Oncogene | 2009 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma
SR Madhunapantula, GP Robertson |
Pigment Cell & Melanoma Research | 2009 |
Redox-directed cancer therapeutics: molecular mechanisms and opportunities
GT Wondrak |
Antioxidants & Redox Signaling | 2009 |
Probing Akt-inhibitor interaction by chemical cross-linking and mass spectrometry
BX Huang, HY Kim |
Journal of the American Society for Mass Spectrometry | 2009 |
Molecular markers of tumor progression in melanoma
J Rother, D Jones |
Current genomics | 2009 |
Use of oral N-acetylcysteine for protection of melanocytic nevi against UV-induced oxidative stress: towards a novel paradigm for melanoma chemoprevention
AG Goodson, MA Cotter, P Cassidy, M Wade, SR Florell, T Liu, KM Boucher, D Grossman |
Clinical cancer research | 2009 |
RGS16 inhibits breast cancer cell growth by mitigating phosphatidylinositol 3-kinase signaling
G Liang, G Bansal, Z Xie, KM Druey |
The Journal of biological chemistry | 2009 |
Ras and Nox: Linked signaling networks?
RF Wu, LS Terada |
Free radical biology & medicine | 2009 |
BI-69A11-mediated inhibition of AKT leads to effective regression of xenograft melanoma
S Gaitonde, SK De, M Tcherpakov, A Dewing, H Yuan, M Riel-Mehan, S Krajewski, G Robertson, M Pellecchia, Z Ronai |
Pigment Cell & Melanoma Research | 2009 |
The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth
CM Cabello, WB 3rd, SD Lamore, S Ley, AS Bause, S Azimian, GT Wondrak |
Free radical biology & medicine | 2009 |
Phosphatidylinositol-3-Kinase as a Therapeutic Target in Melanoma
SA Aziz, M Davies, E Pick, C Zito, L Jilaveanu, RL Camp, DL Rimm, Y Kluger, HM Kluger |
Clinical cancer research | 2009 |
Cancer Abolishes the Tissue Type-Specific Differences in the Phenotype of Energetic Metabolism
Acebo P, Giner D, Calvo P, Blanco-Rivero A, Ortega ÁD, Fernández PL, Roncador G, Fernández-Malavé E, Chamorro M, Cuezva JM |
Translational oncology | 2009 |
Notch1 is an effector of Akt and hypoxia in melanoma development
Barbara Bedogni, James A. Warneke, Brian J. Nickoloff, Amato J. Giaccia and Marianne Broome Powell |
Journal of Clinical Investigation | 2008 |
NOX enzymes as novel targets for drug development
JD Lambeth, KH Krause, RA Clark |
Seminars in Immunopathology | 2008 |
Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy
M Ushio-Fukai, Y Nakamura |
Cancer Letters | 2008 |
Application of angiogenesis to clinical dermatology
LE Fried, JL Arbiser |
Advances in Dermatology | 2008 |
The JmjC Domain Histone Demethylase Ndy1 Regulates Redox Homeostasis and Protects Cells from Oxidative Stress
C Polytarchou, R Pfau, M Hatziapostolou, PN Tsichlis |
Molecular and cellular biology | 2008 |
Malignant Melanoma in the 21st Century: The Emerging Molecular Landscape
Sekulic A, Haluska P Jr, Miller AJ, De Lamo JG, Ejadi S, Pulido JS, Salomao DR, Thorland EC, Vile RG, Swanson DL, Pockaj BA, Laman SD, Pittelkow MR, Markovic SN |
Mayo Clinic proceedings. Mayo Clinic | 2008 |
Why targeted therapy hasn’t worked in advanced cancer
Jack L. Arbiser |
Journal of Clinical Investigation | 2007 |
Understanding signaling cascades in melanoma
P Lopez-Bergami, B Fitchman, Z Ronai |
Photochemistry and Photobiology | 2007 |
Growth factors and oncogenes as targets in melanoma: lost in translation?
L Kwong, L Chin, SN Wagner |
Advances in Dermatology | 2007 |